- Long-Term Effects of COVID-19
- Diabetes and associated disorders
- Celiac Disease Research and Management
- Nutrition and Health in Aging
- Diabetes Management and Research
- Body Composition Measurement Techniques
- COVID-19 and Mental Health
- Lipoproteins and Cardiovascular Health
- Inflammasome and immune disorders
- Pharmaceutical Economics and Policy
- Adipokines, Inflammation, and Metabolic Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Intensive Care Unit Cognitive Disorders
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Exercise and Physiological Responses
- Sleep and related disorders
- Clinical Nutrition and Gastroenterology
- Neurological and metabolic disorders
Vita-Salute San Raffaele University
2022-2025
Istituti di Ricovero e Cura a Carattere Scientifico
2024
Federico II University Hospital
2021-2024
Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele
2024
Abstract Aims No data are available on early initiation of proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) in patients with acute coronary syndrome (ACS) the real world. This study investigates effects PCSK9i started at time ACS hospitalization lipid control and major cardiovascular (CV) events Methods results The outcome was percentage reaching LDL-C target <55 mg/dL first control. clinical incidence composite CV (all-cause death, non-fatal MI, stroke,...
Background UNISCREEN is a general population study aiming at evaluating feasibility and acceptability of universal screening for chronic autoimmune (type 1 diabetes celiac disease) metabolic/cardiovascular diseases (dysglycemia, type 2 diabetes, dyslipidemia, hypertension) across all age groups using capillary blood sampling by fingerprick to measure disease risk markers. Methods was conducted in the Cantalupo fraction, Cerro Maggiore, Milan, Italy, counting 3,061 inhabitants between 100...
A motley postacute symptomatology may develop after COVID-19, irrespective of the acute disease severity, age, and comorbidities. Frail individuals have reduced physiological reserves manifested a worse COVID-19 course, during setting. However, it is still unknown, whether frailty subtend some long manifestations. We explored prevalence disturbs in survivals. This was an observational study. Patients aged 65 years or older were followed-up 1, 3, 6 months hospitalization for pneumonia. total...
Background acute illnesses, like COVID-19, can act as a catabolic stimulus on muscles. So far, no study has evaluated muscle mass and quality through limb ultrasound in post-COVID-19 patients. Methods cross sectional observational study, including patients seen one month after hospital discharge for SARS-CoV-2 pneumonia. The underwent multidimensional evaluation. Moreover, we performed dominant medial gastrocnemius (US) to characterize their quality. Results two hundred fifty-nine...
Coronavirus disease 2019 (COVID-19) may lead to neuropsychiatric sequelae. Palmitoylethanolamide (PEA) is an anti-inflammatory and neuroprotective amide used in depressive syndromes. Here we investigate whether micronized/ultramicronized (m/um) PEA improves sequelae COVID-19 survivors. Patients evaluated at our post-COVID-19 outpatient clinic between February August 2021 presenting manifestations ( n = 98) were offered treatment with m/umPEA 600 mg twice daily for 3 months. Those accepting...
Background: Coronavirus disease (COVID-19) is correlated with a variety of long-term sequelae that affect different aspects health, including physical function. This study investigated the longitudinal changes in handgrip strength (HGS) over six months post-hospital discharge COVID-19 patients and explores associations between HGS, health-related quality life, dyspnoea, exercise capacity, body mass index (BMI). Methods: Adult were followed up at one, three, after hospital discharge. BMI,...
Introduction Chronic autoimmune (type 1 diabetes and coeliac disease) metabolic/cardiovascular 2 diabetes, dyslipidaemia, hypertension) diseases are highly prevalent across all age ranges representing a major public health burden. Universal screening for prediction/early identification of these conditions is potential tool reducing their impact on the general population. The aim this study to assess whether universal using capillary blood sampling feasible at population-based level. Methods...